Rassembler et fédérer tous les acteurs au service de la filière
The unsolvable, solved.
Pall Corporation provides critical filtration, separation and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe.
Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers’ biggest fluid management challenges. And in doing so advance health, safety and environmentally responsible technologies.
Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries.
Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding health, and minimizing emissions and waste.
Your Biotech Journey. Your choice… optimized through Pall’s Process Development Services. Once your new process is up and running, we will continue to support you with ongoing training as required, regular servicing of equipment, and assurance of supply for all your process consumables.
Using our global centers of excellence and our industry leading technology, we specialize in designing, optimizing, and transferring scalable processes from pre-clinical to cGMP commercial manufacturing. Choosing Pall as your process development partner will reduce your development time by leveraging our Industry experts, proven methods, and award-winning integrated bioprocess equipment. Once we design and optimize your process, you will receive specialized support and training from our local technical experts who ensure the seamless and stress-free adoption of the platform at your designated manufacturing facility that will minimize delays in your journey and deliver speed to market
The development of safe and effective viral vectors has accelerated the development of viral based therapies to treat a wide range of diseases. Traditional technology, while seen to work well at a small scale, simply struggles to deliver the desired economic and practical solutions needed for large scale manufacturing.
As the industry quickly evolves, we offer technology that robustly scales from the laboratory and is proven to work in industrial processes to reduce your technology transfer risks. Whether you prefer an end to end, integrated platform to reduce development time or just one technology, we have the products, knowledge and services to help you deliver your gene therapy to market.
Whatever direction your process choices take you in, our range of cell culture, purification and fluid handling technology supports scalable viral vector production such as adeno-associated virus (AAV) and lentivirus (LV).